Brief: Wuxi Biologics To Repurchase Shares Up To Us$400 Million In Open Market
26/05/2026 03:02
May 26 (Reuters) - WuXi Biologics (Cayman) Inc 2269.HK: TO REPURCHASE SHARES UP TO US$400 MILLION IN OPEN MARKET Further company coverage: 2269.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln